Industry News
Pharmaceutical Industry News
Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts efficacy win
Lilly and Boehringer's Jardiance, trailing AZ's Farxiga in chronic kidney disease, posts efficacy win fkansteiner Wed, 03/16/2022 - 10:27
Former J&J CEO Alex Gorsky saw total pay fall last year but remains among pharma’s best-paid
Former J&J CEO Alex Gorsky saw total pay fall last year but remains among pharma's best-paid esagonowsky Wed, 03/16/2022 - 10:27
Biogen piles on more long-term Aduhelm data, linking biomarker to Alzheimer’s clinical benefit
Biogen piles on more long-term Aduhelm data, linking biomarker to Alzheimer’s clinical benefit aliu Wed, 03/16/2022 - 09:59
Consent At Scale: A Permission-Based Marketing Framework
Consent At Scale: A Permission-Based Marketing Framework mwen Wed, 03/16/2022 - 09:30
Biotech execs who pinched Genentech trade secrets headed to prison
Biotech execs who pinched Genentech trade secrets headed to prison fkansteiner Wed, 03/16/2022 - 09:27
Novavax bid for COVID vaccine share isn’t yet working out in Europe: report
Novavax bid for COVID vaccine share isn't yet working out in Europe: report badams Wed, 03/16/2022 - 09:10
Viatris’ copycat to AstraZeneca blockbuster Symbicort passes FDA muster, but legal battle delays launch
Viatris' copycat to AstraZeneca blockbuster Symbicort passes FDA muster, but legal battle delays launch esagonowsky Wed, 03/16/2022 - 08:46
Sprout hopes women will think pink when it comes to treating Hypoactive Sexual Desire Disorder
Sprout hopes women will think pink when it comes to treating Hypoactive Sexual Desire Disorder sharon.coey Wed, 03/16/2022 - 07:21
AstraZeneca teams with oncologists, patient groups on plan to improve ovarian cancer survival
AstraZeneca teams with oncologists, patient groups on plan to improve ovarian cancer survival nmissakian Tue, 03/15/2022 - 15:36
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data esagonowsky Tue, 03/15/2022 - 13:43
In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer
In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 - 11:04
High-risk lung cancer patients aren’t getting screened, survey shows. What can the industry do?
High-risk lung cancer patients aren’t getting screened, survey shows. What can the industry do? mwen Tue, 03/15/2022 - 10:58
After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer
After trial flop, Exelixis drops plan to pair Cabometyx with Roche's Tecentriq in early-stage liver cancer fkansteiner Tue, 03/15/2022 - 10:16
Indian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa
Indian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa jkeenan Tue, 03/15/2022 - 09:57
Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test
Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test ntaylor Tue, 03/15/2022 - 09:53
MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial
MHRA request about ultrasound activation system holds up Exact Therapeutics’ solid tumor trial ntaylor Tue, 03/15/2022 - 09:42
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact ntaylor Tue, 03/15/2022 - 09:30
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa ntaylor Tue, 03/15/2022 - 09:04
Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose
Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose fkansteiner Tue, 03/15/2022 - 08:58
CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cells
CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cells jkeenan Tue, 03/15/2022 - 08:58